42.50
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Arizona State Retirement System Purchases 470 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
What drives Tarsus Pharmaceuticals Inc. stock priceBreakthrough wealth creation - Autocar Professional
Is Tarsus Pharmaceuticals Inc. a good long term investmentOutstanding trading profits - jammulinksnews.com
What makes Tarsus Pharmaceuticals Inc. stock price move sharplyFree Stock Movement Tracking - Newser
What analysts say about Tarsus Pharmaceuticals Inc. stockTremendous gains - jammulinksnews.com
Tarsus Pharmaceuticals Inc. Stock Analysis and ForecastFree Trading Psychology Coaching - jammulinksnews.com
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Tarsus Pharmaceuticals (TARS) and Abbott Laboratories (ABT) - The Globe and Mail
Tarsus Pharmaceuticals Shares Soar 4.47% on Strong Sales, Earnings - AInvest
Tarsus Pharmaceuticals: A Compelling Case for Investment in the Era of Anterior Segment Innovation - AInvest
Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha
William Blair Has Bearish Estimate for TARS Q2 Earnings - Defense World
What is William Blair’s Forecast for TARS FY2026 Earnings? - Defense World
How Tarsus Pharmaceuticals Inc. stock performs during market volatilityFree Investment Risk Control - Newser
Why Tarsus Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Return Potential - Newser
Bank of America Securities Reaffirms Buy Rating for Tarsus Pharmaceuticals at $68.00 - AInvest
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Amalgamated Bank - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Analysts - Defense World
(TARS) Investment Analysis - news.stocktradersdaily.com
Janney Montgomery Scott LLC Sells 2,795 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc.(NasdaqGS:TARS) dropped from Russell Microcap Growth Index - MarketScreener
Tarsus Pharmaceuticals (NASDAQ:TARS) versus Protalix BioTherapeutics (NYSE:PLX) Financial Comparison - Defense World
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq
When (TARS) Moves Investors should Listen - news.stocktradersdaily.com
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India
Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus
Tarsus Pharmaceuticals CCO sells $765,800 in stock - Investing.com Australia
Tarsus Pharmaceuticals CCO sells $765,800 in stock By Investing.com - Investing.com Canada
Certain Common stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - marketscreener.com
Certain Stock Options of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - MarketScreener
Tarsus Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Focus By Investing.com - Investing.com Canada
Transcript : Tarsus Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Stocks Showing Improving Market Leadership: Tarsus Pharmaceuticals Earns 87 RS Rating - MSN
Squarepoint Ops LLC Sells 51,329 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):